164 related articles for article (PubMed ID: 6523302)
21. Isolated limb perfusion for melanoma.
Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
[No Abstract] [Full Text] [Related]
22. Current status of hyperthermic limb perfusion for in-transit melanoma.
Ross MI
Int J Hyperthermia; 2008 May; 24(3):205-17. PubMed ID: 18392999
[TBL] [Abstract][Full Text] [Related]
23. [Regional isolated perfusion: also applicable in elderly patients].
Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
Ned Tijdschr Geneeskd; 2003 Mar; 147(12):529-33. PubMed ID: 12693077
[TBL] [Abstract][Full Text] [Related]
24. Hyperthermic perfusion of extremities for melanoma and soft tissue sarcomas.
Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF; Gutierrez AA
Recent Results Cancer Res; 1977; (59):171-85. PubMed ID: 408886
[No Abstract] [Full Text] [Related]
25. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
Brady MS; Brown K; Patel A; Fisher C; Marx W
Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
[TBL] [Abstract][Full Text] [Related]
26. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB
Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986
[TBL] [Abstract][Full Text] [Related]
27. Isolated limb perfusion.
Moffat EP
Nurs Times; 1969 Jan; 65(5):138-40. PubMed ID: 5763585
[No Abstract] [Full Text] [Related]
28. Some aspects of the treatment of primary malignant melanoma of the extremities by isolated regional perfusion.
Schraffordt Koops H; Oldhoff J; van der Ploeg E; Vermey A; Eibergen R; Beekhuis H
Cancer; 1977 Jan; 39(1):27-33. PubMed ID: 832241
[TBL] [Abstract][Full Text] [Related]
29. The success of TNF alpha in isolated limb perfusion for irresectable extremity soft tissue sarcomas, melanoma and carcinomas: observations in patients and preclinical perfusion models.
Eggermont AM
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1357-70. PubMed ID: 8854755
[No Abstract] [Full Text] [Related]
30. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
Lejeune FJ; Eggermont AM
J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
[No Abstract] [Full Text] [Related]
31. Isolated limb infusion: a review.
Kroon HM; Thompson JF
J Surg Oncol; 2009 Aug; 100(2):169-77. PubMed ID: 19365813
[TBL] [Abstract][Full Text] [Related]
32. Treatment of melanoma in-transit metastases confined to the limb.
Eggermont AM
Cancer Surv; 1996; 26():335-49. PubMed ID: 8783582
[No Abstract] [Full Text] [Related]
33. The use of isolated limb perfusion to manage recurrent malignant melanoma.
Ma D; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
[TBL] [Abstract][Full Text] [Related]
34. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS
J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821
[TBL] [Abstract][Full Text] [Related]
35. Surgical quality control in an international randomized clinical trial.
Schraffordt Koops H
Eur J Surg Oncol; 1992 Dec; 18(6):525-9. PubMed ID: 1478285
[TBL] [Abstract][Full Text] [Related]
36. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
[TBL] [Abstract][Full Text] [Related]
37. [Locoregional recurrence of melanomas of the extremities after hyperthermic extremity perfusion: is reperfusion of value?].
Meyer T; Göhl J; Hohenberger W
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1452-4. PubMed ID: 9931909
[TBL] [Abstract][Full Text] [Related]
38. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
[TBL] [Abstract][Full Text] [Related]
39. Regional hyperthermic perfusion for malignant melanoma.
Hafström LO; Ehrson H; Hugander A; Jönsson PE; Westling H
Prog Clin Biol Res; 1982; 107():793-8. PubMed ID: 7167529
[No Abstract] [Full Text] [Related]
40. Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.
Posner MC; Lienard D; Lejeune FJ; Rosenfelder D; Kirkwood J
Cancer J Sci Am; 1995; 1(4):274-80. PubMed ID: 9166488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
